Exscientia Ltd Adr Stock EBITDA
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Exscientia's long-term financial health and intrinsic value.
Exscientia |
Exscientia Ltd ADR Company EBITDA Analysis
Exscientia's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Exscientia EBITDA | (145.45 M) |
Most of Exscientia's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Exscientia Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Exscientia Ltd ADR reported earnings before interest,tax, depreciation and amortization of (145.45 Million). This is 116.58% lower than that of the Biotechnology sector and 245.23% lower than that of the Health Care industry. The ebitda for all United States stocks is 103.73% higher than that of the company.
Exscientia EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exscientia's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Exscientia could also be used in its relative valuation, which is a method of valuing Exscientia by comparing valuation metrics of similar companies.Exscientia is currently under evaluation in ebitda category among its peers.
Exscientia Fundamentals
| Return On Equity | -0.46 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (10.66) % | |||
| Current Valuation | 346.92 M | |||
| Shares Outstanding | 130.82 M | |||
| Shares Owned By Insiders | 25.90 % | |||
| Shares Owned By Institutions | 20.80 % | |||
| Number Of Shares Shorted | 2.81 M | |||
| Price To Book | 1.95 X | |||
| Price To Sales | 37.10 X | |||
| Revenue | 20.08 M | |||
| Gross Profit | 10.25 M | |||
| EBITDA | (145.45 M) | |||
| Net Income | (145.96 M) | |||
| Cash And Equivalents | 601.89 M | |||
| Cash Per Share | 4.91 X | |||
| Total Debt | 18.92 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 9.08 X | |||
| Book Value Per Share | 1.95 X | |||
| Cash Flow From Operations | (117.6 M) | |||
| Short Ratio | 5.77 X | |||
| Earnings Per Share | (1.51) X | |||
| Price To Earnings To Growth | 0.10 X | |||
| Target Price | 4.35 | |||
| Number Of Employees | 483 | |||
| Beta | 0.84 | |||
| Market Capitalization | 633.18 M | |||
| Total Asset | 510.72 M | |||
| Retained Earnings | (110.47 M) | |||
| Working Capital | 339.87 M | |||
| Net Asset | 510.72 M |
Currently Active Assets on Macroaxis
| RYCEY | Rolls Royce Holdings | |
| VSAT | ViaSat Inc | |
| CIG | Companhia Energetica de | |
| ATEX | Anterix | |
| BBAI | BigBearai Holdings |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |